| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706
The induction of epidermal ornithine decarboxylase (EC 4.1.1.17
Putrescine, when added directly to the assay medium at a 100-µmol dose level inhibited by 97% the TPA-induced ODC activity, but the amount of putrescine (20 µmol) which gave 50% inhibition of the induction of ODC activity in vivo had no effect when added to the assay system. Mixing of soluble extracts from TPA-treated mouse epidermis posttreated either with acetone or putrescine or with mouse epidermis treated with putrescine alone gave essentially additive ODC activity. Furthermore, putrescine did not elicit production of detectable ODC-antizyme activity in mouse epidermis.
Putrescine inhibited the formation of mouse skin papillomas promoted with TPA. Topical application of 20 and 100 µmol of putrescine 2 hr after each application of TPA to mice initiated with 7,12-dimethylbenz[a]anthracene resulted in a 30 and 80% inhibition, respectively, of papilloma formation compared to animals receiving no putrescine.
1 The work was supported by Grants CA-07175, CA-22484, and CA-09135 from the National Cancer Institute, USPHS.
2 To whom requests for reprints should be addressed.
Received 4/10/80.
Accepted 7/24/80.
HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS
Copyright © 1980 by the American Association for Cancer Research.
Cancer Research
Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention
Molecular Cancer Therapeutics
Molecular Cancer Research
Cancer Prevention Research
Cancer Prevention Journals Portal
Cancer Reviews Online
Annual Meeting Education Book
Meeting Abstracts Online